Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Experimental design›Single-blind Control Group Experimental Design
Process / pipelineExperimental design

Single-blind Control Group Experimental Design

Also known as: single-masked controlled experiment, single-blind controlled trial, SB-CGD, single-blind parallel-group design

A single-blind control group experimental design is a controlled experiment in which participants are kept unaware of whether they are receiving the active treatment or a control condition, while researchers and outcome assessors remain unmasked. The design uses a designated control group as the baseline for comparison, allowing causal inference about the treatment effect while limiting participant-driven response biases such as the placebo effect and demand characteristics.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 2 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Single-blind control group experimental design
Control Group Experiment…Crossover Control Group…Double-blind Control Gro…Factorial Control Group…Pretest-Posttest Experim…Randomized Controlled Tr…

When to use it

Use this design when you need causal evidence that a treatment causes an outcome, participant expectation effects are plausible (placebo or nocebo effects, demand characteristics), and it is feasible to keep participants unaware of their group. It is appropriate in clinical, behavioral, educational, and social science experiments where a clear control condition can be defined. Do not use it when full double-blinding is achievable and ethically permissible — double-blinding provides stronger protection against bias. Avoid it when randomization is ethically or logistically impossible (consider a quasi-experimental or natural experiment instead), when the intervention itself makes blinding obvious to participants (e.g., surgery vs. no surgery), or when the outcome measure requires blinded assessment by clinicians (choose double-blind instead).

Strengths & limitations

Strengths
  • Eliminates participant expectation bias, a major threat to internal validity in behavioral and clinical studies.
  • The control group provides a contemporaneous baseline, ruling out history and maturation as alternative explanations.
  • Simpler to implement than double-blind designs when blinding investigators is impractical or unethical.
  • Supports causal inference when combined with randomization, satisfying the gold-standard requirement for many funding bodies and journals.
  • Compatible with CONSORT reporting guidelines, facilitating transparent publication and replication.
Limitations
  • Investigator knowledge of group assignment can introduce assessment bias, particularly when outcome measurement involves clinical judgment or observer ratings.
  • Participant blinding may be compromised if treatment side-effects or characteristics reveal group membership, eroding the masking benefit.
  • Requires careful development and validation of a credible control condition (placebo or active comparator); a poorly matched control inflates apparent treatment effects.
  • Does not control for investigator expectancy effects, which can influence how the intervention is delivered or how outcomes are recorded.

Frequently asked

What is the difference between single-blind and double-blind designs?

In a single-blind design only participants are masked to group assignment; investigators and assessors know who received what. In a double-blind design both participants and investigators (and often assessors) are masked. Double-blinding provides stronger protection against bias because it also prevents investigator expectancy from influencing treatment delivery and outcome measurement.

Is randomization required for this design?

Randomization is strongly recommended and is what makes the design a true experiment capable of supporting causal inference. Without randomization — for example when groups are assigned by convenience — the design becomes quasi-experimental and confounding cannot be ruled out as an explanation for observed differences.

How do I verify that blinding actually worked?

After the study, ask participants to guess their group assignment and compare the accuracy of their guesses to chance (50% correct for a two-group study). Reporting blinding integrity is required by CONSORT guidelines. If blinding was substantially compromised, this must be acknowledged as a limitation and considered when interpreting effect sizes.

When is an active comparator better than a placebo as the control condition?

An active comparator (standard care or established treatment) is preferable when withholding treatment would be unethical, when the research question is comparative effectiveness rather than efficacy against no treatment, or when a plausible placebo cannot be constructed. Active comparators also help maintain blinding when a placebo would be obviously inert.

Can I use this design in behavioral or social science research?

Yes. Single-blind controlled designs are used in psychology, education, and social science whenever the experimental treatment can be delivered without participants knowing the active component — for example, a mindfulness training delivered through an app where the control group uses a structurally equivalent app without mindfulness content. The key requirement is a credible control condition that participants cannot easily distinguish from the treatment.

Sources

  1. Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Houghton Mifflin. ISBN: 978-0395615560
  2. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. DOI: 10.1136/bmj.c332 ↗

How to cite this page

ScholarGate. (2026, June 3). Single-blind Control Group Experimental Design. ScholarGate. https://scholargate.app/en/experimental-design/single-blind-control-group-experimental-design

Related methods

Control Group Experimental DesignCrossover Control Group Experimental DesignDouble-blind Control Group Experimental DesignFactorial Control Group Experimental DesignPretest-Posttest Experimental DesignRandomized Controlled Trial

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Control Group Experimental DesignExperimental design↔ compare
  • Crossover Control Group Experimental DesignExperimental design↔ compare
  • Double-blind Control Group Experimental DesignExperimental design↔ compare
  • Factorial Control Group Experimental DesignExperimental design↔ compare
  • Pretest-Posttest Experimental DesignExperimental design↔ compare
  • Randomized Controlled TrialExperimental design↔ compare
Compare side by side →

Referenced by

Double-blind Control Group Experimental Design

Similar methods

Single-blind Randomized Controlled TrialSingle-blind laboratory experimentDouble-blind Control Group Experimental DesignSingle-blind multi-arm experimentSingle-blind field experimentSingle-blind pretest-posttest experimental designSingle-blind Factorial ExperimentSingle-blind A/B test

Related reference concepts

Randomized Controlled TrialRandomized Controlled TrialRandomization and BlockingCONSORT Statement and RCT ReportingInternal ValidityObservational Study Design

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Single-blind control group experimental design (Single-blind Control Group Experimental Design). Retrieved 2026-07-21 from https://scholargate.app/en/experimental-design/single-blind-control-group-experimental-design · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Classical experimental tradition; blinding formalized in 20th-century clinical trial methodology
Year
Mid-20th century (blinding standards consolidated ~1950s–1970s)
Type
Controlled experimental design
DataType
Quantitative outcome measures (continuous, ordinal, or categorical)
Subfamily
Experimental design
Related methods
Control Group Experimental DesignCrossover Control Group Experimental DesignDouble-blind Control Group Experimental DesignFactorial Control Group Experimental DesignPretest-Posttest Experimental DesignRandomized Controlled Trial
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account